Similar articles for PMID: 24813900

Year	Number of Results
1983	2
1988	1
1990	1
1996	1
2003	3
2004	1
2006	1
2007	1
2008	4
2009	1
2010	11
2011	11
2012	9
2013	4
2014	12
2015	12
2016	7
2017	6
2018	6
2019	2
2020	1
2021	2
2022	1
2024	0

1

OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients.

Icick R, Peoc'h K, Ksouda K, Bloch V, Laplanche JL, Lépine JP, Bellivier F, Vorspan F. Icick R, et al. Psychiatry Res. 2014 Aug 15;218(1-2):259-60. doi: 10.1016/j.psychres.2014.04.035. Epub 2014 Apr 24. Psychiatry Res. 2014. PMID: 24813900 No abstract available.

2

Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.

Tolami HF, Sharafshah A, Tolami LF, Keshavarz P. Tolami HF, et al. J Mol Neurosci. 2020 Apr;70(4):504-513. doi: 10.1007/s12031-019-01443-4. Epub 2019 Dec 18. J Mol Neurosci. 2020. PMID: 31853823

3

A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.

Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, Prince N, Mouly S, Bellivier F, Lépine JP, Laplanche JL, Vorspan F. Icick R, et al. Am J Addict. 2015 Oct;24(7):613-20. doi: 10.1111/ajad.12273. Epub 2015 Sep 1. Am J Addict. 2015. PMID: 26331953

4

The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.

Oueslati B, Moula O, Ghachem R. Oueslati B, et al. Pharmacogenomics. 2018 Jun 1;19(8):741-747. doi: 10.2217/pgs-2018-0017. Epub 2018 May 22. Pharmacogenomics. 2018. PMID: 29785888

5

CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.

AlMeman AA, Ismail R, Perola M. AlMeman AA, et al. Drug Metab Lett. 2016;10(3):213-218. doi: 10.2174/1872312810666160810104040. Drug Metab Lett. 2016. PMID: 27515451

6

OPRM1 and CYP3A4 association with methadone dose in Iranian patients undergoing methadone maintenance therapy.

Akbari A, Kheradmand A, Sina M, Ahmadiani A, Asadi S. Akbari A, et al. J Addict Dis. 2021 Jul-Sep;39(3):357-362. doi: 10.1080/10550887.2021.1886566. Epub 2021 Mar 6. J Addict Dis. 2021. PMID: 33682628

7

Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.

Chawar C, Hillmer A, Lamri A, Kapczinski F, Thabane L, Pare G, Samaan Z. Chawar C, et al. PLoS One. 2021 Dec 15;16(12):e0261201. doi: 10.1371/journal.pone.0261201. eCollection 2021. PLoS One. 2021. PMID: 34910759 Free PMC article.

8

Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.

Wang SC, Tsou HH, Chen CH, Chen YT, Ho IK, Hsiao CF, Chou SY, Lin YF, Fang KC, Huang CL, Su LW, Fang YC, Liu ML, Wu HY, Lin KM, Liu SC, Kuo HW, Chiang IC, Chen AC, Tian JN, Liu YL. Wang SC, et al. Eur Neuropsychopharmacol. 2012 Oct;22(10):695-703. doi: 10.1016/j.euroneuro.2012.02.002. Epub 2012 Mar 9. Eur Neuropsychopharmacol. 2012. PMID: 22406240 Clinical Trial.

9

Suicide risk in depressed methadone-maintained patients: associations with clinical and demographic characteristics.

Phillips J, Carpenter KM, Nunes EV. Phillips J, et al. Am J Addict. 2004 Jul-Sep;13(4):327-32. doi: 10.1080/10550490490482973. Am J Addict. 2004. PMID: 15370931

10

Interindividual variability of methadone response: impact of genetic polymorphism.

Li Y, Kantelip JP, Gerritsen-van Schieveen P, Davani S. Li Y, et al. Mol Diagn Ther. 2008;12(2):109-24. doi: 10.1007/BF03256276. Mol Diagn Ther. 2008. PMID: 18422375 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year